Myomo (MYO) Tops Q3 EPS by 2c, Beats on Revenue; Offers Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. SAP
7. MRK
8. LVS
9. CSX
10. LRCX

Go back to Myomo (MYO) Tops Q3 EPS by 2c, Beats on Revenue; Offers Guidance

Myomo Reports Third Quarter 2025 Financial and Operating Results

November 10, 2025 4:05 PM EST

Revenue of $10.1 million
229 authorizations and orders, highest number this year
Reiterates full year revenue guidance of $40 million to $42 million

Conference call begins today at 4:30pm Eastern time

BURLINGTON, Mass.--(BUSINESS WIRE)-- Myomo, Inc. (NYSE American: MYO) (Myomo or the Company), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today reported financial results for the three and nine months ended September 30, 2025.

Third quarter revenues were at the high end... More